Close Menu

Losing the Award

Three grants issued by the California Institute of Regenerative Medicine have been terminated, reports The Scientist. In reviewing the recipients' first year progress reports, CIRM identified underperforming project. The reviewers then contacted the PIs to learn what the difficulties were and then if the grantees' follow-up report didn't show improvement, the grant was terminated. "Termination is a last option," CIRM's Don Gibbons says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.